ASS-1 deficient bladder cancer cells are ADI-PEG-20 sensitive, activating the GCN2-eIF2α-ATF4 pathway and inducing C/EBP homologous protein (CHOP) expression. Here, ASS1 is linked to urinary bladder carcinoma.